Lensar, Inc.
LNSRLensar, Inc. in brief
Lensar, Inc. is a listed company in the Healthcare sector, based in Orlando, Florida, USA. Its market value was $79 M on 9 October 2026, which makes it the 19,610th largest listed company in the world and the 3,640th largest in the USA on this site. In the year to December 2025 it had sales of $58 M and a net loss of $34 M. It employs about 150 people and Nicholas T. Curtis is its chief executive. By market, the largest shares of its 2025 sales came from USA (59%), Europe (14%) and Asia (Excluding South Korea) (14%). Its shares trade under the symbol LNSR (Nasdaq).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About Lensar, Inc.
We are a commercial-stage medical device company focused on designing, developing and marketing advanced laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Our current systems, the LENSAR Laser System, or LLS, and ALLY Robotic Cataract Laser System®, or ALLY System, or collectively, the Systems, incorporate a range of proprietary technologies designed to assist the surgeon in obtaining better visual outcomes, efficiency and reproducibility by providing advanced imaging, simplified procedure planning, efficient design and precision. We believe the cumulative effect of these technologies results in laser systems that can be quickly and efficiently integrated into a surgeon’s existing practice, is easy to use and provides surgeons the ability to deliver improved visual outcomes with enhanced precision and the ability to do so consistently. The ALLY System combines all of the features from our LLS with a dual-modality laser, integrated in a small, compact cataract treatment system that is designed to allow surgeons to perform sterile cataract surgery in a single operating room. This system is designed to be a significant medical advancement and provide improved efficiency and financial benefit to a surgeon’s practice and to ambulatory surgery centers, or ASCs. The ALLY System received clearance from the U.S. Food and Drug Administration, or FDA, in June 2022, and we executed a controlled and targeted initial launch of the ALLY System in August 2022. The ALLY System is available to all U.S. and EU cataract surgeons and has also received regulatory clearance in India, Taiwan, as well as certain other countries.
From the company's annual report filed with the US SEC: read the report
Lensar, Inc. timeline
- 2005
- •· approximateFirst filing with the US SECThe company's first electronic filing in SEC EDGAR.
- 2006
- ✎Renamed LensAR IncFormerly LaserSoft Vision Inc.
- 2025
- 💰Record revenue of $58 millionFY2025, the highest of the 7 years on record.
Events of Lensar, Inc. from SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in USA: #4,730 (Jan 2022) · #5,066 (Dec 2022) · #4,895 (Jul 2023) · #4,077 (Jan 2024) · #1,832 (Mar 2026) · #3,418 (Aug 2026) · #3,619 (Oct 2026)
Key ratios
- P/E ratio (TTM)
- 2.4×
- Price / sales (TTM)
- 1.3×
- Price / book
- —
- Free cash flow yield
- -18.8%
- Net margin (TTM)
- 56.1%
- Operating margin
- -42.1%
- Return on equity
- —
- Liabilities / assets
- 117.1%
- Revenue growth
- +9.3%
- R&D / revenue
- 9.6%
- Revenue per employee
- $390 K
- Profit per employee
- $-229 K
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $58M | +9.3% | $-25M | $-34M | -58.7% |
| Dec 2024 | $53M | +26.9% | $-11M | $-31M | -58.7% |
| Dec 2023 | $42M | +19.2% | $-12M | $-14M | -34.1% |
| Dec 2022 | $35M | +2.6% | $-20M | $-20M | -56.3% |
| Dec 2021 | $34M | +30.6% | $-20M | $-20M | -56.9% |
| Dec 2020 | $26M | -13.6% | $-19M | $-20M | -74.9% |
| Dec 2019 | $31M | — | $-13M | $-15M | -48.0% |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Dec 2025 | $-15M | $0M | $-15M | $-2.87 | — |
| Dec 2024 | $-2M | $0M | $-2M | $-2.73 | — |
| Dec 2023 | $-10M | $0M | $-10M | $-1.31 | — |
| Dec 2022 | $-15M | $0M | $-15M | $-1.96 | — |
| Dec 2021 | $-9M | $0M | $-9M | $-2.09 | — |
| Dec 2020 | $-14M | $0M | $-14M | $-4.28 | — |
| Dec 2019 | $-13M | $0M | $-13M | $-13.70 | — |
Quarterly results
Latest quarter to Sep 2026: revenue $14M (-1.3% on a year earlier), net income $-5M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.
SEC filings
- Nov 10, 202610-QQuarterly report · period to Sep 2026
- Nov 10, 20268-KCurrent reportResults of operations
- Aug 13, 202610-QQuarterly report · period to Jun 2026
- Aug 13, 20268-KCurrent reportResults of operations
- Aug 10, 20268-KCurrent reportShareholder vote
- Jun 23, 2026DEF 14AProxy statement
- May 29, 20268-KCurrent reportDirectors or officers changed · Other events
- May 8, 202610-QQuarterly report · period to Mar 2026
- May 8, 20268-KCurrent reportResults of operations
- Apr 30, 202610-K/AAnnual report (amended) · period to Dec 2025
- Apr 15, 20268-KCurrent reportDirectors or officers changed
- Mar 31, 202610-KAnnual report · period to Dec 2025
Official filings of Lensar, Inc. with the US Securities and Exchange Commission.
Annual results
- Revenue
- $58 M
- Operating income
- $-25 M
- Net income
- $-34 M
For year ending December-2025 · source: SEC filing
Balance sheet
- Total assets
- $71 M
- Total liabilities
- $84 M
- Total equity
- $-26 M
As of December-2025
Top 67 institutional investors in Lensar, Inc.#
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 1 | Brandes Investment Partners, LP | 1,254,384 | +178,984 (+16.64%) | 10.20% | $8 M | Nov 16, 2026 |
| 2 | Vanguard Capital Management LLC | 402,806 | 0 (0.00%) | 3.28% | $3 M | Nov 13, 2026 |
| 3 | RBF Capital, LLC | 227,915 | +39,254 (+20.81%) | 1.85% | $2 M | Nov 13, 2026 |
| 4 | Marshall Wace, LLP | 184,000 | New | 1.50% | $1 M | Nov 13, 2026 |
| 5 | BlackRock, Inc. | 166,384 | -18,649 (-10.08%) | 1.35% | $1 M | Nov 13, 2026 |
| 6 | CSS Llc/il | 120,450 | -43,000 (-26.31%) | 0.98% | $1 M | Nov 16, 2026 |
| 7 | Geode Capital Management, LLC | 111,703 | -2,628 (-2.30%) | 0.91% | $1 M | Nov 6, 2026 |
| 8 | Mink Brook Asset Management LLC | 100,000 | New | 0.81% | $1 M | Nov 13, 2026 |
| 9 | DCF Advisers, LLC | 94,000 | -24,217 (-20.49%) | 0.76% | $1 M | Nov 4, 2026 |
| 10 | Millennium Management LLC | 88,229 | -32,451 (-26.89%) | 0.72% | $1 M | Nov 16, 2026 |
| 11 | Dimensional Fund Advisors LP | 72,891 | -78,718 (-51.92%) | 0.59% | $0 M | Nov 4, 2026 |
| 12 | State Street Corp | 71,983 | -9,000 (-11.11%) | 0.59% | $0 M | Nov 12, 2026 |
| 13 | Citadel Advisors LLC | 71,278 | +35,531 (+99.40%) | 0.58% | $0 M | Nov 16, 2026 |
| 14 | Yakira Capital Management, Inc. | 64,918 | -18,370 (-22.06%) | 0.53% | $0 M | Nov 13, 2026 |
| 15 | Vanguard Fiduciary Trust Co | 64,233 | +6,402 (+11.07%) | 0.52% | $0 M | Nov 13, 2026 |
| 16 | Gabelli Funds LLC | 59,000 | 0 (0.00%) | 0.48% | $0 M | Nov 12, 2026 |
| 17 | Jane Street Group, LLC | 55,991 | +35,628 (+174.96%) | 0.46% | $0 M | Nov 12, 2026 |
| 18 | Susquehanna International Group, LLP | 54,496 | +10,241 (+23.14%) | 0.44% | $0 M | Nov 16, 2026 |
| 19 | Dynamic Technology Lab Private Ltd | 54,166 | 0 (0.00%) | 0.44% | $0 M | Nov 13, 2026 |
| 20 | Essex Investment Management Co LLC | 53,258 | 0 (0.00%) | 0.43% | $0 M | Oct 19, 2026 |
| 21 | Centiva Capital, LP | 50,602 | +1,350 (+2.74%) | 0.41% | $0 M | Nov 13, 2026 |
| 22 | Goldman Sachs Group Inc | 49,171 | -10,358 (-17.40%) | 0.40% | $0 M | Nov 16, 2026 |
| 23 | Hillsdale Investment Management Inc. | 46,000 | New | 0.37% | $0 M | Nov 12, 2026 |
| 24 | Quinn Opportunity Partners LLC | 39,349 | +10,000 (+34.07%) | 0.32% | $0 M | Nov 10, 2026 |
| 25 | LPL Financial LLC | 35,696 | +4,028 (+12.72%) | 0.29% | $0 M | Nov 6, 2026 |
Show all 67: investors 26 to 67
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 26 | GTS Securities LLC | 33,974 | +8,970 (+35.87%) | 0.28% | $0 M | Nov 16, 2026 |
| 27 | GAMCO Investors, Inc. Et Al | 33,000 | 0 (0.00%) | 0.27% | $0 M | Nov 12, 2026 |
| 28 | Deltec Asset Management LLC | 32,500 | -32,500 (-50.00%) | 0.26% | $0 M | Oct 26, 2026 |
| 29 | Squarepoint Ops LLC | 30,484 | New | 0.25% | $0 M | Nov 9, 2026 |
| 30 | Royal Bank Of Canada | 28,452 | +4,988 (+21.26%) | 0.23% | $0 M | Nov 16, 2026 |
| 31 | Morgan Stanley | 28,119 | +19,627 (+231.12%) | 0.23% | $0 M | Nov 13, 2026 |
| 32 | Envestnet Asset Management Inc | 26,825 | +3,503 (+15.02%) | 0.22% | $0 M | Nov 16, 2026 |
| 33 | XTX Topco Ltd | 26,267 | New | 0.21% | $0 M | Nov 16, 2026 |
| 34 | Renaissance Technologies LLC | 25,000 | New | 0.20% | $0 M | Nov 12, 2026 |
| 35 | Northern Trust Corp | 21,992 | -25 (-0.11%) | 0.18% | $0 M | Nov 16, 2026 |
| 36 | HRT Financial LP | 20,427 | +9,486 (+86.70%) | 0.17% | $0 M | Nov 13, 2026 |
| 37 | Occudo Quantitative Strategies LP | 19,989 | New | 0.16% | $0 M | Nov 16, 2026 |
| 38 | Sanctuary Advisors, LLC | 17,295 | +498 (+2.96%) | 0.14% | $0 M | Nov 13, 2026 |
| 39 | Atria Investments, Inc | 16,849 | +1,666 (+10.97%) | 0.14% | $0 M | Oct 15, 2026 |
| 40 | State of Wyoming | 16,718 | New | 0.14% | $0 M | Oct 28, 2026 |
| 41 | Murchinson Ltd. | 13,223 | 0 (0.00%) | 0.11% | $0 M | Nov 13, 2026 |
| 42 | Legato Capital Management LLC | 12,569 | 0 (0.00%) | 0.10% | $0 M | Nov 10, 2026 |
| 43 | &partners | 11,403 | +849 (+8.04%) | 0.09% | $0 M | Nov 16, 2026 |
| 44 | UBS Group AG | 10,936 | -74,698 (-87.23%) | 0.09% | $0 M | Nov 10, 2026 |
| 45 | Nuveen, LLC | 8,078 | New | 0.07% | $0 M | Nov 10, 2026 |
| 46 | Russell Investments Group, Ltd. | 5,007 | -4,836 (-49.13%) | 0.04% | $0 M | Nov 6, 2026 |
| 47 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 3,509 | +2,007 (+133.62%) | 0.03% | $0 M | Nov 16, 2026 |
| 48 | Vanguard Global Advisers, LLC | 3,178 | 0 (0.00%) | 0.03% | $0 M | Nov 13, 2026 |
| 49 | National Bank Of Canada /fi/ | 2,050 | 0 (0.00%) | 0.02% | $0 M | Nov 16, 2026 |
| 50 | FMR LLC | 2,019 | -1,170 (-36.69%) | 0.02% | $0 M | Nov 10, 2026 |
| 51 | Tower Research Capital LLC (TRC) | 1,965 | +1,701 (+644.32%) | 0.02% | $0 M | Nov 16, 2026 |
| 52 | Jpmorgan Chase & Co | 1,508 | +1,083 (+254.82%) | 0.01% | $0 M | Nov 12, 2026 |
| 53 | Fifth Third Bancorp | 1,498 | 0 (0.00%) | 0.01% | $0 M | Nov 5, 2026 |
| 54 | GAMMA Investing LLC | 893 | -370 (-29.30%) | 0.01% | $0 M | Oct 8, 2026 |
| 55 | Wells Fargo & Company/mn | 318 | -50 (-13.59%) | 0.00% | $0 M | Nov 16, 2026 |
| 56 | Osaic Holdings, Inc. | 273 | 0 (0.00%) | 0.00% | $0 M | Nov 12, 2026 |
| 57 | BNP Paribas Financial Markets | 233 | -146 (-38.52%) | 0.00% | $0 M | Nov 12, 2026 |
| 58 | Caitong International Asset Management Co., Ltd | 191 | +184 (+2628.57%) | 0.00% | $0 M | Oct 29, 2026 |
| 59 | Steward Partners Investment Advisory, LLC | 169 | 0 (0.00%) | 0.00% | $0 M | Nov 13, 2026 |
| 60 | Farther Finance Advisors, LLC | 149 | 0 (0.00%) | 0.00% | $0 M | Oct 8, 2026 |
| 61 | PNC Financial Services Group, Inc. | 135 | -216 (-61.54%) | 0.00% | $0 M | Nov 6, 2026 |
| 62 | Harbour Investments, Inc. | 75 | 0 (0.00%) | 0.00% | $0 M | Nov 9, 2026 |
| 63 | SBI Securities Co., Ltd. | 57 | -1 (-1.72%) | 0.00% | $0 M | Oct 22, 2026 |
| 64 | Lanark Financial, Inc. | 41 | 0 (0.00%) | 0.00% | $0 M | Oct 26, 2026 |
| 65 | Blume Capital Management, Inc. | 7 | 0 (0.00%) | 0.00% | $0 M | Oct 26, 2026 |
| 66 | Barclays PLC | 1 | -456 (-99.78%) | 0.00% | $0 M | Nov 6, 2026 |
| 67 | Buck Wealth Strategies, LLC | 1 | 0 (0.00%) | 0.00% | $0 M | Oct 28, 2026 |
Mutual funds holding Lensar, Inc.#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 Brandes Small Cap Value FundBrandes Investment Partners LP | 532,616 | $3 M | 2.6% | 0.48% | +9.9% | Jun 30, 2026 |
| 🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc. | 275,971 | $2 M | 1.4% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc. | 101,379 | $1 M | 0.50% | <0.01% | −0.4% | Jun 30, 2026 |
| 🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC | 52,439 | $0 M | 0.26% | <0.01% | +3.2% | May 31, 2026 |
| 🇺🇸 Vanguard Russell 2000 Index FundThe Vanguard Group, Inc. | 48,568 | $0 M | 0.24% | <0.01% | +2.0% | May 31, 2026 |
| 🇺🇸 U.S. Targeted Value PortfolioDimensional Fund Advisors LP | 53,149 | $0 M | 0.26% | <0.01% | −8.1% | Jul 31, 2026 |
| 🇺🇸 1290 VT GAMCO Mergers & Acquisitions PortfolioEquitable Investment Management Group, LLC | 33,000 | $0 M | 0.16% | 0.11% | no change | Jun 30, 2026 |
| 🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors | 32,515 | $0 M | 0.16% | 0.01% | +40% | Jun 30, 2026 |
| 🇺🇸 U.S. Small Cap PortfolioDimensional Fund Advisors LP | 35,350 | $0 M | 0.18% | <0.01% | −12% | Jul 31, 2026 |
| 🇺🇸 U.S. Micro Cap PortfolioDimensional Fund Advisors LP | 22,817 | $0 M | 0.11% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 The Gabelli ABC FundGabelli Funds, LLC | 20,000 | $0 M | 0.10% | 0.03% | no change | Jun 30, 2026 |
| 🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC | 17,123 | $0 M | 0.08% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Goldman Sachs ActiveBeta U.S. Small Cap Equity ETFGoldman Sachs Asset Management, L.P. | 14,533 | $0 M | 0.07% | <0.01% | +1.4% | May 31, 2026 |
| 🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC | 14,419 | $0 M | 0.07% | <0.01% | +9.0% | May 31, 2026 |
| 🇺🇸 Dimensional U.S. Small Cap ETFDimensional Fund Advisors LP | 16,558 | $0 M | 0.08% | <0.01% | −21% | Jul 31, 2026 |
| 🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors | 11,740 | $0 M | 0.06% | <0.01% | −95% | Jun 30, 2026 |
| 🇺🇸 Vanguard Russell 2000 Growth Index FundThe Vanguard Group, Inc. | 9,127 | $0 M | 0.05% | <0.01% | +3.0% | May 31, 2026 |
| 🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC | 8,155 | $0 M | 0.04% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Nuveen Nasdaq 100 Dynamic Overwrite FundNuveen Fund Advisors, LLC | 7,859 | $0 M | 0.04% | <0.01% | −56% | Jun 30, 2026 |
| 🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc. | 7,146 | $0 M | 0.04% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Invesco Russell 2000 Dynamic Multifactor ETFInvesco Capital Management LLC | 5,544 | $0 M | 0.03% | 0.01% | new | May 31, 2026 |
| 🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc. | 5,198 | $0 M | 0.03% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 iShares Russell 2000 Growth ETFBlackRock Fund Advisors | 4,257 | $0 M | 0.02% | <0.01% | −95% | Jun 30, 2026 |
| 🇺🇸 Schwab Total Stock Market Index FundCharles Schwab Investment Management, Inc. | 4,846 | $0 M | 0.02% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Small Cap Index FundThe Variable Annuity Life Insurance Company | 3,936 | $0 M | 0.02% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC | 2,176 | $0 M | 0.01% | <0.01% | +21% | Jun 30, 2026 |
| 🇺🇸 Bridge Builder Small/Mid Cap Growth FundOLIVE STREET INVESTMENT ADVISERS LLC | 1,996 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 U.S. Small Cap Value PortfolioDimensional Fund Advisors LP | 1,627 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 SA U.S. Small Company FundFocus Advisor Solutions, LLC | 1,385 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Siit Extended Market Index FundSEI INVESTMENTS MANAGEMENT CORPORATION | 1,200 | $0 M | <0.01% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Avantis U.S. Small Cap Equity ETFAmerican Century ETF Trust | 1,009 | $0 M | <0.01% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC | 866 | $0 M | <0.01% | <0.01% | −95% | Jun 30, 2026 |
| 🇺🇸 Vanguard Russell 3000 Index FundThe Vanguard Group, Inc. | 802 | $0 M | <0.01% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 LVIP Dimensional U.S. Core Equity 1 FundLincoln Financial Investments Corporation | 606 | $0 M | <0.01% | <0.01% | −63% | Jun 30, 2026 |
| 🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC | 588 | $0 M | <0.01% | <0.01% | −95% | Jun 30, 2026 |
| 🇺🇸 U.S. Core Equity 2 PortfolioDimensional Fund Advisors LP | 682 | $0 M | <0.01% | <0.01% | −97% | Jul 31, 2026 |
| 🇺🇸 ProShares Russell 2000 High Income ETFPROSHARE ADVISORS LLC | 449 | $0 M | <0.01% | <0.01% | +8.5% | May 31, 2026 |
| 🇺🇸 JNL/DFA U.S. Core Equity FundJackson National Asset Management, LLC | 440 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 ProShares Ultra Russell2000PROSHARE ADVISORS LLC | 350 | $0 M | <0.01% | <0.01% | −41% | May 31, 2026 |
| 🇺🇸 ProShares UltraPro Russell2000PROSHARE ADVISORS LLC | 353 | $0 M | <0.01% | <0.01% | −40% | May 31, 2026 |
| 🇺🇸 Destinations Small-Mid Cap Equity FundBrinker Capital Investments, LLC | 329 | $0 M | <0.01% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Small-Cap Index PortfolioPacific Life Fund Advisors LLC | 137 | $0 M | <0.01% | <0.01% | −95% | Jun 30, 2026 |
| 🇺🇸 ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC | 118 | $0 M | <0.01% | <0.01% | −95% | Jun 30, 2026 |
| 🇺🇸 NVIT Small Cap Index FundNATIONWIDE FUND ADVISORS | 98 | $0 M | <0.01% | <0.01% | −95% | Jun 30, 2026 |
| 🇺🇸 EQ/Morgan Stanley Small Cap Growth PortfolioEquitable Investment Management Group, LLC | 84 | $0 M | <0.01% | <0.01% | −94% | Jun 30, 2026 |
| 🇺🇸 BlackRock Small Cap Index V.I. FundBlackRock Advisors, LLC | 66 | $0 M | <0.01% | <0.01% | −94% | Jun 30, 2026 |
| 🇺🇸 Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P. | 54 | $0 M | <0.01% | <0.01% | +17% | Jun 30, 2026 |
| 🇺🇸 PD Small-Cap Growth Index PortfolioPacific Life Fund Advisors LLC | 32 | $0 M | <0.01% | <0.01% | −94% | Jun 30, 2026 |
| 🇺🇸 EQ/Franklin Small Cap Value Managed Volatility PortfolioEquitable Investment Management Group, LLC | 22 | $0 M | <0.01% | <0.01% | −94% | Jun 30, 2026 |
| 🇺🇸 Dimensional US Core Equity 1 ETFDimensional Fund Advisors LP | 4 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 50 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
Insider trading at Lensar, Inc.#
Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Gary M. WinerDirector | Grant or award | +4,169 | $4.530 | $19 K | 109,804 | Form 4 |
| filed | Nicholas T. CurtisChief Executive Officer, Director | Grant or award | +130,662 | — | — | 1.12 M | Form 4 |
| filed | Gary M. WinerDirector | Grant or award | +17,421 | — | — | 105,635 | Form 4 |
| filed | Aimee S. WeisnerDirector | Grant or award | +17,421 | — | — | 110,368 | Form 4 |
| filed | Alan B. ConnaughtonChief Operating Officer | Grant or award | +34,843 | — | — | 389,173 | Form 4 |
| filed | Richard L. LindstromDirector | Grant or award | +17,421 | — | — | 263,831 | Form 4 |
| filed | Kendra WongPrincipal Accounting Officer | Grant or award | +13,066 | — | — | 56,481 | Form 4 |
| filed | William J. LinkDirector | Grant or award | +17,421 | — | — | 568,062 | Form 4 |
Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals
Markets and events: Lensar, Inc.#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
Stock splits: 1-for-9 reverse split
Trading halts
- 2026-03-16 20:25 UTC, code T3, resumed 21:00 UTC
- 2025-03-24 11:55 UTC, code T3, resumed 12:30 UTC
Fails to deliver
- : 3 shares at $6.45
- : 50 shares at $8.44
- : 1,191 shares at $8.72
- : 12 shares at $8.09
- : 848 shares at $8.27
Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables
Lensar, Inc. scorecard#
Passes 9 of the 19 checks that could be worked out: strongest in growth (4 of 6), weakest in profitability (1 of 4). Fiscal year 2025; market cap of Oct 9, 2026.
Valuation3 of 5
- ✓P/E below its peers' median2.4×P/E 2.4× against Healthcare's median of 30.0×.
- ✗Price to book below its peers' medianNo price to bookShareholders' equity is negative.
- ✓Price to sales below its peers' median1.3×Price to sales 1.3× against Healthcare's median of 3.8×.
- ✗Free cash flow yield above 5%-18.8%Free cash flow is -18.8% of the market value.
- ✓Earnings yield above the 10-year Treasury yield42.6%Earnings yield 42.6% against the 10-year Treasury's 5.15% on 2026-11-13.
- –The price assumes slower growth than the last three years'Free cash flow of the last three years is missing or below zero on average.
Growth4 of 6
- ✓Revenue grew in the newest year9.2%Revenue up 9.2% in fiscal 2025.
- ✓Revenue up more than 5% a year over three years18.2%18.2% a year over the three years to fiscal 2025.
- ✓Faster growth over three years than its peers' median18.2%18.2% a year against Healthcare's median of 8.5% (549 companies).
- ✗Earnings per share grew in the newest year-2.87 vs -2.73Diluted EPS -2.87 in fiscal 2025 against -2.73 the year before (report's currency).
- ✗Net income higher than five years earlier-$34 M-$34 M in fiscal 2025 against -$20 M in 2020.
- ✓Revenue rose in at least four of the last five years5 of 5Revenue rose in 5 of the five years to fiscal 2025.
Profitability1 of 4
- ✗Profitable in the newest year-$34 MNet income -$34 M in fiscal 2025.
- ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2025.
- ✗Operating margin above its peers' median-42.1%-42.1% against Healthcare's median of -7.7% (674 companies).
- –Return on equity above 15%No return on equity (equity missing or negative).
- –Return on invested capital above 10%No return on invested capital on file.
- ✓Operating margin wider than three years earlier-42.1%-42.1% in fiscal 2025 against -57.1% in 2022.
Financial health1 of 3
- ✓Short-term assets cover short-term liabilities1.1×Current ratio 1.15 at the end of fiscal 2025.
- –Debt below equityDebt or equity is not on file (or equity is negative).
- –Net debt below three years of EBITDANet debt to EBITDA is not on file.
- –Operating income covers interest five timesInterest expense is not on file.
- ✗Cash from operations positive in each of the last three years0 of 3Positive in 0 of the three years to fiscal 2025.
- ✗Altman Z-score outside the distress zone-3.13Z-score -3.13 (distress zone) for fiscal 2025.
Shareholder returns0 of 1
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- ✗Share count up no more than 2% in a year3.8%Diluted shares up 3.8% in fiscal 2025.
- –Dividends and buybacks above 3% of the market valueDividends and buybacks are not on file.
- –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.
Worked out from the statements as filed (sec), the medians of Healthcare, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Financial analysis, 2025#
Worked out from Lensar, Inc.'s statements, beside the median of Healthcare.
| Ratio | Trend | 2025 | Median of peers |
|---|---|---|---|
| Operating margin | -42.1% | -7.7% | |
| Net margin | -58.7% | -8.1% | |
| Revenue growth, 3 years a year | 18.2% | 8.5% | |
| Revenue growth | 9.3% | 10.2% | |
| Free cash flow margin | -25.5% | -1.3% |
2of 8on the Piotroski tests of financial strength
- Net loss of $34 million, the 7th loss-making year in a row.
- Free cash flow was negative: -$15 million.
- Shareholders' equity is negative: -$26 million.
- Revenue has grown 5 years in a row.
Lensar, Inc.: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2025to Dec 31, 2025 | FY 2024to Dec 31, 2024 | FY 2023to Dec 31, 2023 | FY 2022to Dec 31, 2022 | FY 2021to Dec 31, 2021 | FY 2020to Dec 31, 2020 | FY 2019to Dec 31, 2019 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 58+9.2%100% | 53+26.9%100% | 42+19.2%100% | 35+2.6%100% | 34+30.6%100% | 26−13.6%100% | 31—100% | |
| Cost of revenue | 31+13.3%53.6% | 28+31.3%51.7% | 21+36.7%49.9% | 15−7.4%43.6% | 17+35.1%48.2% | 12−28.9%46.6% | 17—56.7% | |
| Research and development | 5.6+5.5%9.6% | 5.3−13.2%10.0% | 6.1−48.0%14.6% | 12−4.4%33.4% | 12+63.6%35.9% | 7.6−0.2%28.6% | 7.6—24.8% | |
| Selling, general and administrative | 45+70.5%77.3% | 26+1.5%49.5% | 26−3.9%61.9% | 27+13.7%76.8% | 24+0.5%69.3% | 24+38.6%90.1% | 17—56.2% | |
| Operating income | −25—−42.1% | −11—−19.9% | −12—−29.0% | −20—−57.1% | −20—−57.0% | −19—−70.1% | −13—−41.6% | |
| Interest expense and finance costs | — | — | — | — | — | 1.3−33.0%5.1% | 2.0—6.6% | |
| Provision for credit losses | −0.0—−0.0% | −0.0−110%−0.0% | 0.0+100%0.0% | 0.0−77.8%0.0% | 0.0—0.1% | −0.0—−0.0% | — | |
| Other non-operating income (expense) | 0.6−3.6%1.1% | 0.7−5.4%1.2% | 0.7+165%1.7% | 0.3+416%0.7% | 0.1−25.0%0.1% | 0.1+17.2%0.3% | 0.1—0.2% | |
| Income before tax | −34—−58.7% | −31—−58.7% | −14—−34.1% | −20—−56.3% | −20—−56.9% | −20—−75.0% | −15—−48.0% | |
| Net income including minority interests | −34—−58.7% | −31—−58.7% | −14—−34.1% | −20—−56.3% | −20—−56.9% | −20—−75.0% | −15—−48.0% | |
| Net income attributable to shareholders | −34—−58.7% | −31—−58.7% | −14—−34.1% | −20—−56.3% | −20—−56.9% | −20—−75.0% | −15—−48.0% | |
| Earnings per share, basic | -2.87—— | -2.73—— | -1.31—— | -1.96—— | -2.09—— | -4.28—— | -13.70—— | |
| Earnings per share, diluted | -2.87—— | -2.73—— | -1.31—— | -1.96—— | -2.09—— | -4.28—— | -13.70—— | |
| Shares, weighted average (basic) | 12+3.8%— | 12+5.0%— | 11+8.0%— | 10+8.4%— | 9.4—— | — | — | |
| Shares, weighted average (diluted) | 12+3.8%— | 12+5.0%— | 11+8.0%— | 10+8.4%— | 9.4+103%— | 4.6+332%— | 1.1—— | |
| Balance sheet | ||||||||
| Cash and cash equivalents | 13−20.2%18.2% | 16−21.1%24.5% | 21+40.5%29.6% | 15−53.6%26.3% | 32−22.1%47.6% | 41+780%51.3% | 4.6—13.4% | |
| Short-term investments | 5.0−19.2%7.0% | 6.2+79.8%9.3% | 3.4—4.9% | — | — | — | — | |
| Receivables | 6.4+4.8%8.9% | 6.1+52.1%9.2% | 4.0−33.8%5.7% | 6.0+30.2%10.8% | 4.6+131%7.0% | 2.0−40.5%2.5% | 3.4—9.8% | |
| Inventory | 22+88.3%30.1% | 11−27.2%17.2% | 16+33.6%22.5% | 12+80.9%21.0% | 6.5−51.8%9.8% | 13+67.1%17.0% | 8.1—23.3% | |
| Other current assets | 0.6−62.8%0.8% | 1.6−31.7%2.4% | 2.4+123%3.4% | 1.1−37.5%1.9% | 1.7−8.5%2.6% | 1.9+200%2.3% | 0.6—1.8% | |
| Current assets | 47+11.4%65.5% | 42−9.6%63.3% | 46+37.8%66.7% | 34−24.8%60.4% | 45−23.2%67.4% | 58+240%73.8% | 17—49.8% | |
| Property, plant and equipment | 0.5−23.9%0.7% | 0.7−2.2%1.0% | 0.7+20.6%1.0% | 0.6−25.5%1.0% | 0.8−9.1%1.1% | 0.8+15.6%1.1% | 0.7—2.1% | |
| Right-of-use (leased) assets | 2.6+3.6%3.6% | 2.5+15.2%3.7% | 2.1−18.6%3.1% | 2.6−16.5%4.7% | 3.2−14.1%4.7% | 3.7+330%4.6% | 0.9—2.5% | |
| Other intangible assets | 5.2−15.1%7.3% | 6.1−44.6%9.2% | 11−9.0%15.8% | 12+11.5%21.7% | 11−10.2%16.4% | 12−9.4%15.3% | 13—38.7% | |
| Long-term investments | — | — | 0.5—0.7% | — | — | — | — | |
| Total assets | 71+7.7%100% | 66−4.7%100% | 70+24.6%100% | 56−16.0%100% | 66−16.0%100% | 79+129%100% | 35—100% | |
| Accounts payable | 19+217%26.6% | 6.0+49.6%9.0% | 4.0−26.1%5.8% | 5.4+101%9.7% | 2.7+8.6%4.1% | 2.5+57.3%3.1% | 1.6—4.6% | |
| Current liabilities | 41+170%56.8% | 15+29.0%22.6% | 12+1.8%16.7% | 11+31.1%20.5% | 8.7+2.9%13.1% | 8.5+8.1%10.7% | 7.8—22.7% | |
| Lease liabilities (non-current) | 2.0−4.9%2.8% | 2.1+19.4%3.2% | 1.8−23.0%2.5% | 2.3−18.9%4.1% | 2.8−15.4%4.2% | 3.3+895%4.2% | 0.3—1.0% | |
| Total liabilities | 84+75.6%117% | 48+113%71.9% | 22+61.7%32.2% | 14+19.6%24.8% | 12−2.7%17.4% | 12−81.7%15.1% | 65—188% | |
| Retained earnings | −178—−249% | −143—−216% | −112—−161% | −98—−175% | −78—−117% | −58—−73.3% | −38—−111% | |
| Shareholders' equity | −26−635%−36.4% | 4.9−85.5%7.3% | 33−20.4%48.0% | 42−23.5%75.2% | 55−18.3%82.6% | 67—84.9% | −31—−88.5% | |
| Total liabilities and equity | 71+7.7%100% | 66−4.7%100% | 70+24.6%100% | 56−16.0%100% | 66−16.0%100% | 79+129%100% | 35—100% | |
| Shares outstanding | 12+2.9%— | 12+2.9%— | 11+2.1%— | 11+0.9%— | 11+0.5%— | 11+922%— | 1.1—— | |
| Cash-flow statement | ||||||||
| Share-based compensation | 3.1+17.9%5.4% | 2.7−51.9%5.0% | 5.5−16.2%13.1% | 6.6−3.7%18.7% | 6.9−24.1%19.9% | 9.0+8768%34.3% | 0.1—0.3% | |
| Cash from operating activities | −15—−25.4% | −2.3—−4.3% | −9.7—−22.9% | −15—−42.0% | −9.0—−26.0% | −14—−52.3% | −13—−41.2% | |
| Capital expenditure | −0.1—−0.1% | −0.2—−0.3% | −0.2—−0.6% | −0.1—−0.3% | −0.4—−1.0% | −0.4—−1.4% | −0.4—−1.3% | |
| Intangible assets bought | — | — | — | — | — | — | −1.7—−5.6% | |
| Cash from investing activities | 1.3—2.2% | −2.2—−4.0% | −4.2—−9.9% | −0.1—−0.3% | −0.4—−1.0% | −0.3—−1.2% | −2.1—−6.8% | |
| Shares issued | — | — | — | — | — | 16—62.3% | — | |
| Cash from financing activities | 10+13051%17.6% | 0.1−99.6%0.1% | 20—46.9% | −2.0−652%−5.6% | 0.4−99.3%1.0% | 50+214%190% | 16—52.2% | |
| Change in cash | −3.3—−5.6% | −4.4−173%−8.1% | 5.9—14.1% | −17—−48.0% | −9.0−125%−26.0% | 36+2723%136% | 1.3—4.2% | |
| Report | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | |
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the same quarter a year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | Last 12 months4 quarters to Sep 30, 2026 | Q3 FY2026to Sep 30, 2026 | Q2 FY2026to Jun 30, 2026 | Q1 FY2026to Mar 31, 2026 | Q4 FY2025to Dec 31, 2025 | Q3 FY2025to Sep 30, 2025 | Q2 FY2025to Jun 30, 2025 | Q1 FY2025to Mar 31, 2025 | Q4 FY2024to Dec 31, 2024 | Q3 FY2024to Sep 30, 2024 | Q2 FY2024to Jun 30, 2024 | Q1 FY2024to Mar 31, 2024 | Q4 FY2023to Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||||||
| Revenue | 60+1.6%100% | 14−1.3%100% | 16+18.4%100% | 13−5.2%100% | 16*−4.2%100% | 14+5.7%100% | 14+10.3%100% | 14+33.7%100% | 17*+38.2%100% | 14—100% | 13—100% | 11—100% | 12*—100% | |
| Cost of revenue | 29−9.5%48.0% | 6.0−27.9%42.2% | 6.7−2.8%40.7% | 7.0+0.2%52.5% | 9.1*−5.6%56.7% | 8.3+13.8%57.8% | 6.9+18.7%49.6% | 7.0+42.9%49.7% | 9.6*+38.3%57.5% | 7.3—53.7% | 5.8—46.1% | 4.9—46.5% | 7.0*—57.5% | |
| Research and development | 5.3−7.1%8.8% | 1.3−4.4%9.2% | 1.3−10.7%7.7% | 1.4−9.7%10.3% | 1.3*−2.9%8.1% | 1.4+13.7%9.5% | 1.4+5.7%10.2% | 1.5+6.2%10.8% | 1.3*−8.7%8.0% | 1.2—8.9% | 1.3—10.7% | 1.4—13.6% | 1.5*—12.1% | |
| Selling, general and administrative | 27−35.0%45.0% | 8.1−32.9%57.1% | 6.1−47.3%37.2% | 2.5−77.3%18.8% | 10*+51.2%64.5% | 12+97.8%84.0% | 12+71.8%83.7% | 11+64.1%78.7% | 6.8*+7.2%40.8% | 6.1—44.9% | 6.8—53.7% | 6.8—64.2% | 6.4*—52.7% | |
| Operating income | −2.0—−3.3% | −1.4—−10.1% | 2.1—12.9% | 2.2—16.7% | −4.9*—−30.7% | −7.6—−52.9% | −6.3—−45.1% | −5.8—−40.9% | −1.3*—−7.7% | −1.2—−9.2% | −5.3—−41.8% | −2.9—−26.9% | −3.0*—−24.5% | |
| Provision for credit losses | −0.0—−0.0% | −0.0*—−0.0% | 0.0*—0.0% | −0.0—−0.0% | −0.0*−125%−0.0% | −0.0*—−0.0% | −0.0*—−0.0% | −0.0—−0.0% | 0.0*−20.0%0.0% | −0.0*—−0.0% | −0.0*—−0.0% | −0.0—−0.0% | 0.0*—0.0% | |
| Other non-operating income (expense) | 0.5−14.5%0.9% | 0.1−43.6%0.5% | 0.2−11.4%1.0% | 0.1−8.8%1.1% | 0.2*+1.3%0.9% | 0.1−13.1%0.9% | 0.2+20.6%1.4% | 0.2−19.7%1.1% | 0.1*−36.1%0.9% | 0.2—1.1% | 0.2—1.3% | 0.2—1.9% | 0.2*—1.9% | |
| Income tax | — | 0—0.0% | 0—0.0% | 0—0.0% | — | 0—0.0% | 0—0.0% | 0—0.0% | — | 0—0.0% | 0—0.0% | 0—0.0% | — | |
| Net income including minority interests | 34—56.1% | −4.7*—−33.4% | 3.5*—21.4% | 36—271% | −1.5*—−9.1% | −3.7*—−25.9% | −1.8*—−12.7% | −27—−193% | −19*—−112% | −1.5*—−11.1% | −9.0*—−71.6% | −2.2—−20.4% | −3.9*—−32.4% | |
| Net income attributable to shareholders | 34—56.1% | −4.7—−33.4% | 3.5—21.4% | 36—271% | −1.5*—−9.1% | −3.7—−25.9% | −1.8—−12.7% | −27—−193% | −19*—−112% | −1.5—−11.1% | −9.0—−71.6% | −2.2—−20.4% | −3.9*—−32.4% | |
| Earnings per share, basic | — | -0.38—— | 0.14—— | 1.56—— | — | -0.31—— | -0.15—— | -2.32—— | — | -0.13—— | -0.79—— | -0.19—— | — | |
| Earnings per share, diluted | — | -0.38—— | 0.10—— | 0.00—— | — | -0.31—— | -0.15—— | -2.32—— | — | -0.13—— | -0.79—— | -0.19—— | — | |
| Shares, weighted average (basic) | 12+2.9%— | 12+2.9%— | 12+3.0%— | 12+3.3%— | — | 12+3.8%— | 12+4.2%— | 12+3.4%— | — | 12—— | 11—— | 11—— | — | |
| Shares, weighted average (diluted) | 12+2.9%— | 12+2.9%— | 23+92.9%— | 15+31.0%— | — | 12+3.8%— | 12+4.2%— | 12+3.4%— | — | 12—— | 11—— | 11—— | — | |
| Balance sheet | ||||||||||||||
| Cash and cash equivalents | 13—18.8% | 13+65.3%18.8% | 14+89.7%19.5% | 12−36.1%18.9% | 13−20.2%18.2% | 7.6−26.9%10.9% | 7.2−13.7%10.2% | 20+40.0%26.8% | 16−21.1%24.5% | 10—16.8% | 8.3—13.5% | 14—21.1% | 21—29.6% | |
| Short-term investments | 0—0.0% | 0−100%0.0% | 0−100%0.0% | 1.0−82.4%1.5% | 5.0−19.2%7.0% | 9.2+20.9%13.2% | 13+122%18.7% | 5.7+44.2%7.8% | 6.2+79.8%9.3% | 7.6—12.3% | 5.9—9.7% | 4.0—6.0% | 3.4—4.9% | |
| Receivables | 5.1—7.7% | 5.1−12.9%7.7% | 6.2+23.7%8.9% | 4.9−28.9%7.4% | 6.4+4.8%8.9% | 5.9+34.9%8.4% | 5.0−15.4%7.1% | 6.9+71.1%9.4% | 6.1+52.1%9.2% | 4.4—7.1% | 5.9—9.6% | 4.0—6.1% | 4.0—5.7% | |
| Inventory | 25—37.5% | 25+22.1%37.5% | 25+29.2%35.8% | 23+50.7%34.9% | 22+88.3%30.1% | 21+38.3%29.3% | 19+7.3%27.3% | 15−14.0%21.0% | 11−27.2%17.2% | 15—24.0% | 18—29.2% | 18—26.9% | 16—22.5% | |
| Other current assets | 1.1—1.6% | 1.1+41.9%1.6% | 1.9+93.6%2.8% | 0.6−54.5%0.9% | 0.6−62.8%0.8% | 0.8−54.5%1.1% | 1.0−46.5%1.4% | 1.4−41.7%1.9% | 1.6−31.7%2.4% | 1.7—2.7% | 1.9—3.0% | 2.4—3.6% | 2.4—3.4% | |
| Current assets | 44—66.3% | 44+0.1%66.3% | 47+2.5%67.6% | 42−13.8%64.0% | 47+11.4%65.5% | 44+12.8%63.3% | 46+14.0%65.1% | 49+15.9%67.4% | 42−9.6%63.3% | 39—63.5% | 40—65.5% | 42—64.2% | 46—66.7% | |
| Property, plant and equipment | 0.5—0.8% | 0.5−5.6%0.8% | 0.4−26.9%0.6% | 0.5−20.8%0.7% | 0.5−23.9%0.7% | 0.6−18.0%0.8% | 0.6−14.9%0.9% | 0.6−22.8%0.8% | 0.7−2.2%1.0% | 0.7—1.1% | 0.7—1.2% | 0.7—1.1% | 0.7—1.0% | |
| Right-of-use (leased) assets | — | — | — | — | 2.6+3.6%3.6% | — | — | — | 2.5+15.2%3.7% | — | — | — | 2.1—3.1% | |
| Other intangible assets | 4.5—6.7% | 4.5−16.9%6.7% | 4.7−16.2%6.8% | 5.0−15.6%7.5% | 5.2−15.1%7.3% | 5.4−14.5%7.7% | 5.7−14.1%8.0% | 5.9−45.3%8.1% | 6.1−44.6%9.2% | 6.3—10.2% | 6.6—10.7% | 11—16.3% | 11—15.8% | |
| Long-term investments | — | — | — | — | — | — | — | — | — | 0.5—0.8% | 1.2—2.0% | 1.2—1.9% | 0.5—0.7% | |
| Total assets | 67—100% | 67−4.5%100% | 70−1.2%100% | 66−9.2%100% | 71+7.7%100% | 70+13.2%100% | 70+14.7%100% | 73+10.3%100% | 66−4.7%100% | 62—100% | 61—100% | 66—100% | 70—100% | |
| Accounts payable | 9.9—14.7% | 9.9−33.4%14.7% | 11−1.1%16.1% | 10+30.2%15.2% | 19+217%26.6% | 15+283%21.1% | 11+175%16.1% | 7.8+88.2%10.6% | 6.0+49.6%9.0% | 3.9—6.2% | 4.1—6.7% | 4.1—6.2% | 4.0—5.8% | |
| Current liabilities | 20—29.5% | 20−44.5%29.5% | 20−34.7%28.2% | 18−34.5%26.9% | 41+170%56.8% | 36+206%50.9% | 30+190%42.7% | 27+160%37.2% | 15+29.0%22.6% | 12—18.8% | 10—16.9% | 10—15.8% | 12—16.7% | |
| Lease liabilities (non-current) | 1.4—2.1% | 1.4−36.6%2.1% | 1.6−12.2%2.3% | 1.8−8.5%2.7% | 2.0−4.9%2.8% | 2.2+65.8%3.1% | 1.8+23.6%2.6% | 2.0+21.7%2.7% | 2.1+19.4%3.2% | 1.3—2.1% | 1.5—2.4% | 1.6—2.4% | 1.8—2.5% | |
| Total liabilities | 42—62.9% | 42−48.7%62.9% | 41−48.7%58.8% | 42−48.8%62.9% | 84+75.6%117% | 82+223%117% | 80+232%113% | 81+296%111% | 48+113%71.9% | 25—41.1% | 24—39.0% | 21—31.1% | 22—32.2% | |
| Retained earnings | −142—−212% | −142—−212% | −138—−198% | −141—−213% | −178—−249% | −176—−251% | −172—−245% | −171—−234% | −143—−216% | −125—−201% | −123—−200% | −114—−172% | −112—−161% | |
| Shareholders' equity | 11—16.5% | 11—16.5% | 15—21.4% | 11—16.3% | −26−635%−36.4% | −26−214%−36.9% | −23−197%−32.7% | −22−170%−30.3% | 4.9−85.5%7.3% | 23—36.7% | 24—38.5% | 32—48.1% | 33—48.0% | |
| Total liabilities and equity | 67—100% | 67−4.5%100% | 70−1.2%100% | 66−9.2%100% | 71+7.7%100% | 70+13.2%100% | 70+14.7%100% | 73+10.3%100% | 66−4.7%100% | 62—100% | 61—100% | 66—100% | 70—100% | |
| Shares outstanding | 12—— | 12+3.0%— | 12+2.9%— | 12+2.6%— | 12+2.9%— | 12+2.8%— | 12+3.4%— | 12+3.5%— | 12+2.9%— | 12—— | 12—— | 11—— | 11—— | |
| Cash-flow statement | ||||||||||||||
| Share-based compensation | 2.8−5.9%4.6% | 0.90.0%6.0% | 0.3−54.7%2.1% | 0.7+5.5%5.1% | 0.9*+31.9%5.4% | 0.9+27.2%5.9% | 0.8+12.2%5.5% | 0.7+0.3%4.6% | 0.7*−18.9%4.0% | 0.7—4.9% | 0.7—5.4% | 0.7—6.2% | 0.8*—6.7% | |
| Cash from operating activities | −4.6—−7.7% | −0.9*—−6.1% | −0.1*—−0.8% | −4.3—−31.8% | 0.6*−83.1%3.9% | −3.5*−211%−24.5% | −5.0*—−35.9% | −6.9—−49.0% | 3.7*—21.9% | 3.2*—23.3% | −3.8*—−29.9% | −5.3—−50.1% | −0.5*—−4.0% | |
| Capital expenditure | — | −0.1*—−0.8% | — | — | 0*—0.0% | 0*—0.0% | −0.1*—−0.6% | −0.0—−0.0% | −0.0*—−0.0% | −0.0*—−0.1% | −0.1*—−0.9% | −0.0—−0.2% | −0.0*—−0.4% | |
| Cash from investing activities | 9.1—15.1% | −0.1*−103%−0.8% | 1.0*—5.9% | 4.0+653%29.8% | 4.2*+113%26.5% | 4.0*—27.9% | −7.5*—−53.8% | 0.5—3.8% | 2.0*—11.9% | −0.9*—−6.7% | −2.0*—−16.0% | −1.2—−11.6% | −4.0*—−32.8% | |
| Cash from financing activities | 0.5−94.6%0.9% | 0.0*—0.2% | 0.2*+151%1.4% | −0.2−102%−1.6% | 0.5*+176%3.0% | 0*—0.0% | 0.1*−27.9%0.7% | 9.7—68.4% | 0.2*+17.8%1.0% | −0.1*—−0.7% | 0.1*—1.0% | −0.1—−1.2% | 0.1*—1.2% | |
| Change in cash | 5.0—8.3% | −0.9*−294%−6.7% | 1.1*—6.5% | −0.5−115%−3.6% | 5.3*−8.3%33.3% | 0.5*−77.4%3.4% | −12*—−89.0% | 3.3—23.2% | 5.8*—34.8% | 2.2*—15.9% | −5.7*—−44.9% | −6.7—−62.9% | −4.3*—−35.5% | |
| Report | Worked out | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | |
* Worked out from reported figures: a quarter the company states only within a year-to-date figure (cash flows are reported that way), or the fourth quarter as the fiscal year minus the first nine months.
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
What Lensar, Inc. sells: revenue by product line, fiscal 2025#
As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2024. Lines can overlap (a total and its parts), so they are not added up.
Products and services
- Product(total)$46 M79%+12%
- Service(total)$6 M9.8%+17%
Countries and regions
- 🇺🇸 USA$34 M59%+19%
- Europe$8 M14%-17%
- Asia (Excluding South Korea)$8 M14%+46%
- 🇰🇷 South Korea$1 M1.1%-22%
- Other$0 M0.4%-57%
Source: SEC annual report (XBRL data) · as of Dec 31, 2025
Where Lensar, Inc. operates: 2 countries#
Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue.
| Country | Presence | Revenue there |
|---|---|---|
| 🇺🇸 USA | Headquarters1 office | $34 M59% |
| 🇰🇷 South Korea | $1 M1.1% |
Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided
Executive pay at Lensar, Inc.#
From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.
| Fiscal year | CEO total pay | Actually paid | Other executives, average | $100 invested |
|---|---|---|---|---|
| 2025Mr. Curtis | $2.3 M | $3.2 M | $929 K | $331 |
| 2024Mr. Curtis | $1.6 M | $3.0 M | $916 K | $255 |
Source: SEC proxy statement (Form DEF 14A) · as of Dec 31, 2025
Events at Lensar, Inc.#
What the company reported to the SEC within four business days (Form 8-K), newest first.
No warning signs in the last three years: no bankruptcy, delisting notice, withdrawn financial statements, auditor change, cybersecurity incident, debt called early or impairment was reported.
Directors and officers 2 · Material agreement 2 · Agreement ended 2 · Shareholder vote 4 · Results announced 11
| Filed | What happened | Filing |
|---|---|---|
| Results announced | 8-K | |
| Results announced | 8-K | |
| Shareholder vote | 8-K | |
| Directors and officers | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Results announced | 8-K | |
| Material agreementAgreement ended | 8-K | |
| Shareholder vote | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Shareholder vote | 8-K | |
| Results announced | 8-K | |
| Material agreement | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Agreement endedResults announced | 8-K | |
| Shareholder vote | 8-K | |
| Results announced | 8-K |
Source: SEC EDGAR, Form 8-K item numbers · as of Nov 10, 2026
Acquisitions and funding#
10 private funding rounds before listing
Private share sales · funding history
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| May 2023 | $20 M | Private placement after listing | $10 to $50 million | 1 | equity, options | SEC |
| Jul 2014 | $16 M | No. 10 | $10 to $50 million | 2 | equity | SEC |
| Dec 2013 | $10 M | No. 9 | $10 to $50 million | 14 | equity | SEC |
| Aug 2013 | $17 M | No. 8 | $10 to $50 million | 3 | equity | SEC |
| Nov 2012 | $5 M | No. 7 | $2 to $10 million | 3 | equity | SEC |
| Mar 2012 | $24 M | No. 6 | $10 to $50 million | 2 | equity | SEC |
| Dec 2011 | $1 M | No. 5 | Under $2 million | 1 | debt, options | SEC |
| Oct 2011 | $4 M | No. 4 | $2 to $10 million | 1 | equity | SEC |
| Aug 2011 | $5 M | No. 3 | $2 to $10 million | 2 | debt, options | SEC |
| Jul 2010 | $7 M | No. 2 | $2 to $10 million | 2 | equity | SEC |
| Jul 2009 | $7 M | No. 1 | $2 to $10 million | 3 | equity | SEC |
Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.
How Lensar, Inc. compares in Healthcare
- Market cap$79 M · higher than 24% of 2,013
- Revenue$58 M · higher than 35% of 1,795
- Net margin56.1% · higher than 99% of 1,485
- Revenue growth9.3% · higher than 53% of 1,003
- P/E ratio2.4× · lower than 99% of 605
- Price / sales1.3× · lower than 77% of 1,071
- FCF yield-18.8% · higher than 32% of 835
Peer comparison · Healthcare
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Lensar, Inc.🇺🇸 | $79 M | 2.4× | 56.1% | +9.3% |
| Eli Lilly and Company🇺🇸 | $1.20 T | 43.4× | 31.9% | +44.7% |
| Johnson & Johnson🇺🇸 | $652.5 B | 40.5× | 16.2% | +6.0% |
| AbbVie Inc.🇺🇸 | $514.0 B | 49.7× | 15.7% | +8.6% |
| Roche Holding AG🇨🇭 | $370.3 B | 29.1× | 19.0% | — |
| UnitedHealth Group Incorporated🇺🇸 | $367.7 B | 23.1× | 3.5% | +11.8% |
| Merck & Co., Inc.🇺🇸 | $359.8 B | 146.7× | 3.6% | +1.3% |
| Novartis AG🇨🇭 | $286.8 B | 20.5× | 24.7% | — |
| Thermo Fisher Scientific Inc.🇺🇸 | $253.8 B | 35.9× | 14.9% | +3.9% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
Sources and freshness
- Market cap:
- Oct 9, 2026
- Annual results:
- For year ending December-2025
- Balance sheet:
- As of December-2025
- Employees:
- As of December 31, 2025
- Profile updated:
- Nov 20, 2026
Figures from Market data, SEC filing, value.today research, SEC annual report; financial statements from SEC filings.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Lensar, Inc.? Verify and update this profile — free
Show Lensar, Inc.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.